Screener
X4 Pharmaceuticals XFOR Q1 2026 earnings
Reported May 6, 2026 · Before market open
Revenue$2.5MMiss by $731.0K
EPS-$0.16Beat by $0.04
Revenue estimate$3.2M
EPS estimate-$0.20
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$2.3M
EPS estimate-$0.19
Versus estimates
Revenue
Diluted EPS
FAQ
- When did X4 Pharmaceuticals report Q1 2026 earnings?
- X4 Pharmaceuticals (XFOR) reported Q1 2026 earnings on May 6, 2026 before market open.
- What were X4 Pharmaceuticals's Q1 2026 revenue and EPS?
- X4 Pharmaceuticals reported revenue of $2.5M and eps of $-0.16 for Q1 2026.
- Did X4 Pharmaceuticals beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $3.2M by $731.0K. EPS beat the consensus estimate of $-0.20 by $0.04.
- How did X4 Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 91.4% from $28.8M a year earlier.
- Where can I find X4 Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001501697-26-000040) directly on SEC EDGAR. The filing index links above go to sec.gov.
